2014 欧盟-治疗肠易激综合征药物研发的临床评价指南

2014-09-25 欧盟药品管理局欧盟药品管理局官网

本指南旨在强调欧盟对开发治疗肠易激综合征类新医药产品临床评价的原则立场。

中文标题：

英文标题：

Guideline on the evaluation of medicinal products for the treatment of irritable bowel syndrome

发布机构：

欧盟药品管理局

发布日期：

2014-09-25

简要介绍：

本指南旨在强调欧盟对开发治疗肠易激综合征类新医药产品临床评价的原则立场。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=5ea8f1c00111a4b3, title=2014 欧盟-治疗肠易激综合征药物研发的临床评价指南, enTitle=Guideline on the evaluation of medicinal products for the treatment of irritable bowel syndrome, guiderFrom=欧盟药品管理局官网, authorId=null, author=, summary=本指南旨在强调欧盟对开发治疗肠易激综合征类新医药产品临床评价的原则立场。, cover=, journalId=null, articlesId=null, associationId=1065, associationName=欧盟药品管理局, associationIntro=欧盟药品管理局(Europen Medicines Agency，EMA), copyright=0, guiderPublishedTime=Thu Sep 25 08:00:00 CST 2014, originalUrl=http://guide.medlive.cn/guideline/8118, linkOutUrl=, content=本指南旨在强调欧盟对开发治疗肠易激综合征类新医药产品临床评价的原则立场。, tagList=[TagDto(tagId=594, tagName=肠易激综合征)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2434, appHits=10, showAppHits=0, pcHits=1683, showPcHits=982, likes=99, shares=1, comments=0, approvalStatus=1, publishedTime=Thu Sep 25 00:00:00 CST 2014, publishedTimeString=2014-09-25, pcVisible=1, appVisible=1, editorId=null, editor=Irea, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=null, createdTime=Thu Sep 25 00:00:00 CST 2014, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 03:23:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2014 欧盟-治疗肠易激综合征药物研发的临床评价指南)])